Rapid Therapeutic Science Laboratories, Inc.
RTSL
Revenue
0.00
0.000.00%
3 Months ChangeAssets
2.07M
▲39.87k▲1.96%
3 Months ChangeLiabilities
4.81M
▼-58.56k▼-1.20%
3 Months ChangeFree Cash Flow
-41.81k
▲692.81k▲94.31%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-12-06
Form 8-K
ID: 0001393905-23-000402
2023-08-23
Form 8-K
ID: 0001393905-23-000314
2023-08-14
Form 10-Q
ID: 0001393905-23-000312
2023-07-14
Form 8-K
ID: 0001393905-23-000283
2023-05-12
Form 10-Q
ID: 0001393905-23-000220
2022-11-10
Form 10-Q
ID: 0001393905-22-000447
2022-08-12
Form 10-Q
ID: 0001393905-22-000302
2022-05-31
Form 8-K
ID: 0001393905-22-000176
2022-05-11
Form 10-Q
ID: 0001393905-22-000151
2022-03-31
Form 8-K
ID: 0001393905-22-000102